Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
536,082
-
Shares change
-
+5,345
-
Total reported value, excl. options
-
$98,232,493
-
Value change
-
+$981,063
-
Number of buys
-
36
-
Number of sells
-
-30
-
Price
-
$183.14
Significant Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q3 2021
112 filings reported holding IHE - ISHARES TR - U.S. PHARMA ETF as of Q3 2021.
ISHARES TR - U.S. PHARMA ETF (IHE) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 536,082 shares
.
Largest 10 shareholders include WELLS FARGO & COMPANY/MN (61,316 shares), MORGAN STANLEY (47,452 shares), CITADEL ADVISORS LLC (41,635 shares), ROYAL BANK OF CANADA (38,060 shares), BROWN ADVISORY INC (37,506 shares), RAYMOND JAMES & ASSOCIATES (30,092 shares), BANK OF AMERICA CORP /DE/ (26,151 shares), LPL Financial LLC (24,699 shares), MURPHY CAPITAL MANAGEMENT INC (18,705 shares), and Steward Partners Investment Advisory, LLC (16,594 shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.